LightOx Ltd

At the end of the week our Biology Team Leader Cole Sims will be heading to Dubai, UAE for Arab Health Exhibition 2025 on a Trade Mission with Department for Business and Trade. Cole will be spreading the word about the development of our treatments for oral cancer and wound care. Be sure to say hello 👋🏽 #DBTGlobal #ArabHealth25 #HealthcareUK #Lifescience #healthcare #innovation #uk #medtech #digitalhealth

Our CSO Carrie Ambler took to the mic 🎤 today to take part in a podcast that explores her journey at the helm of LightOx Ltd . Thanks to Claire Rutherford from DefinitionIP for the invite. We look forward to the episode !

As 2024 comes to close, all of us at LightOx would like to wish you a very Merry Christmas and all the best for the New Year 🎄

  The Biology Team are on the road! Cole Sims and Natalie Young, PhD are excited to be exhibiting our light activated treatment for oral pre-cancers at the Oncology and Precision Medicine conference hosted by Bionow. They will be exhibiting on Tuesday 10th December with a stand to help explain and publicise our innovation to others in the oncology field. They will also be around on the evening for the Biotech and Beers event so do catch up with them there if you can’t make the conference itself.

Emerging Antimicrobials and Diagnostics Event 2024 – 26th and 27th November It's been a great couple of days at the Emerging Antimicrobials and Diagnostics event in Amsterdam with David Chisholm sharing his insights about LXD231: LightOx’s light-activated antimicrobial product for the removal of bioburden in infected wounds. David said; “This year’s Emerging Antimicrobials and Diagnostics (EADA) conference in Amsterdam was a real highlight. It was a pleasure to speak to leaders in the antimicrobials and AMR fields from across Europe and share updates on our LXD231 technology in such a fantastic venue. It’s clear LightOx are developing something innovative in the sector, and it was encouraging to receive such a broad range of feedback and opportunities to collaborate in this critically important field.”

Great to see our very own Cole Sims doing a fantastic job in chairing the Antibiotic Resistance and Mechanisms (ARM) Workshop for Researchers 2024 today.

Just arrived and very much looking forward to chairing the first session tomorrow morning! Thanks for the opportunity Ronan McCarthy! LightOx Ltd Ryan Waite

Emerging Antimicrobials and Diagnostics -EADA Event 2024 – 26th and 27th November   With only a week to go our Head of Technology, David Chisholm will be speaking at the Emerging Antimicrobials and Diagnostics Event in Amsterdam (EADA) on 26th and 27th November.   EADA 2024 aims to boost international collaboration and joint innovation in the domain of antimicrobials and diagnostics to enhance the global curbing of antimicrobial resistance.    At the event David will be talking about LXD231: LightOx’s light-activated antimicrobial product for the removal of bioburden in infected wounds.   https://lnkd.in/eCbzsfx7

  Wounds UK Annual Conference 11th-13th November   David Chisholm, Head of Technology and Cole Sims, Biology Team Leader at LightOx attended and presented at the Wounds UK Annual Conference 2024 in Harrogate from 11th-13th November. The event highlighted the latest clinical opinion, research, and policy from around the UK.   At the event David shared updates on the technical development of LXD231: LightOx’s light-activated antimicrobial product for the removal of bioburden in infected wounds.   The three-day conference also included the Foot in Diabetes Annual Conference which took place on 12th November. This year’s event focussed on the patient and foot care and renewing the ever-present passion and drive to deliver excellent patient care. #WoundsUK #wuk24

Something that I now do a lot more, but after a conversation last week, someone asked me how would I know how to check myself? This video is short, but helpful, and spotting things as early as possible is key. https://lnkd.in/eTHgb4sj